Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1999
10/28/1999CA2325391A1 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999CA2324995A1 Methods and products related to metabolic interactions in disease
10/28/1999CA2324975A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999CA2324442A1 Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata
10/28/1999CA2324297A1 Sh2 domain-containing peptides
10/28/1999CA2323571A1 Novel human k+ ion channel and therapeutic applications thereof
10/28/1999CA2269103A1 Peptides binding to bone marrow stromal cell antigen
10/27/1999EP0952450A1 Diagnostic reagent for Puumala virus infection
10/27/1999EP0952222A1 Transgenic plants presenting a modified inulin producing profile
10/27/1999EP0952219A1 Recombinant proteins for the fusion of the porcine reproductive and respiratory syndrome virus and its use in diagnosis
10/27/1999EP0952217A2 Use of a recombinant protein as receptor of a hepatitis virus
10/27/1999EP0952215A2 Protease for activating clotting factor VII
10/27/1999EP0952159A2 Use of somatostatin derivatives and/or of phenylhydrazone derivatives as antinflammatory or analgetic agents
10/27/1999EP0952158A1 Modified methylotrophic p. pastoris yeast which secretes human groth hormone
10/27/1999EP0951911A2 Method for administering aspb28-human insulin
10/27/1999EP0951910A2 Method for administering monomeric insulin analogs
10/27/1999EP0951837A1 Bioactive peptides, uses thereof and process for the production of same
10/27/1999EP0951564A1 Method for the detection of compounds that modulate the effects of the obese (ob) protein
10/27/1999EP0951563A1 A new eia test using non-dentured hiv antigen for early detection of hiv infection
10/27/1999EP0951559A1 Recombinant pox virus for immunization against tumor-associated antigens
10/27/1999EP0951555A2 Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
10/27/1999EP0951554A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
10/27/1999EP0951553A2 Adenovirus e4 proteins for inducing cell death
10/27/1999EP0951552A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications
10/27/1999EP0951551A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
10/27/1999EP0951550A1 Mammalian cytokine related to il10
10/27/1999EP0951549A1 Mammalian chemokines
10/27/1999EP0951548A1 Mammalian icyp (iodocyanopindolol)receptor and its applications
10/27/1999EP0951547A1 NOVEL SEQUENCES OF p56 PROTEINS WHICH AFFECT K-ATP CHANNELS
10/27/1999EP0951546A2 Compositions and methods of use for osteoclast inhibitory factors
10/27/1999EP0951545A2 Human gtp-binding proteins
10/27/1999EP0951544A2 Methods for administration of recombinant gene delivery vehicles for treatment of human disease
10/27/1999EP0951543A1 Human glycine transporter
10/27/1999EP0951542A2 Secreted proteins and polynucleotides encoding them
10/27/1999EP0951541A1 Biomarkers and targets for diagnosis, prognosis and management of prostate disease
10/27/1999EP0951538A2 PARTIAL SEQUENCES OF PURINE BIOSYNTHESIS GENES FROM $i(ASHBYA GOSSYPII) AND THEIR USE IN THE MICROBIAL RIBOFLAVIN SYNTHESIS
10/27/1999EP0951537A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
10/27/1999EP0951532A1 Bivalent agonists for g-protein coupled receptors
10/27/1999EP0951481A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
10/27/1999EP0951480A1 Method and novel compounds for use therein
10/27/1999EP0951479A1 Trh receptor
10/27/1999EP0951478A1 Polysaccharide-peptide derivatives
10/27/1999EP0951477A1 Lymphocyte stimulating factor from trypanosoma
10/27/1999EP0951476A2 Complement inhibitor
10/27/1999EP0951475A1 Metastatic colorectal cancer vaccine
10/27/1999EP0951472A1 Peptide compositions with growth factor-like activity
10/27/1999EP0951469A1 Novel compounds
10/27/1999EP0951466A2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/27/1999EP0951464A1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/27/1999EP0951296A1 NOVEL FtsL
10/27/1999EP0951295A1 Methods and compositions useful for inhibition of angiogenesis
10/27/1999EP0951294A1 Wound healing formulations containing human plasma fibronectin
10/27/1999EP0951292A1 Methods for treating an ischemic disorder and improving stroke outcome
10/27/1999EP0830601B1 Use of a phycobiliprotein-linker peptide complex as a fluorescent tracer
10/27/1999EP0769144B1 Assay for inhibitors of dp-1 and other dp proteins
10/27/1999EP0759938A4 Neurogenic differentiation (neurod) genes and proteins
10/27/1999EP0590082B1 Antisense oligonucleotide inhibition of the ras gene
10/27/1999EP0533862B1 Recombinant human factor viii derivatives
10/27/1999EP0167575B2 Cardiodilatine, a peptide hormone and production process thereof
10/27/1999CN1233290A Antifungal proteins, DNA coding therefore, and hosts incorporating same
10/27/1999CN1233289A TNF-Beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
10/27/1999CN1233288A GnRH-leukotoxin chimeras
10/27/1999CN1233257A Polypeptide transition metal salts and method of enhancing anti-HIV activity of polypeptide
10/27/1999CN1233189A Treatment of asthma with TNFR-Ig
10/27/1999CN1233187A HIVp-17 peptide fragment, compositions containing and methods for producing and using same
10/27/1999CN1232666A Development and utilization of chitin
10/27/1999CN1045995C Method of inducing lysine overproduction in plants
10/27/1999CN1045994C Modification of plant viruses or their effects
10/27/1999CA2269995A1 Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects
10/26/1999USRE36359 Long chain carboxylic acid imide ester
10/26/1999US5973233 Cytoplasmic male sterility system production canola hybrids
10/26/1999US5973231 For transforming hosts with pesticidal protein; killing pests with host transformed to express protein
10/26/1999US5973229 Isolated, purified protein encoding cdna; to alter plant's sensitivity to certain herbicides
10/26/1999US5973225 Cloned and sequenced gene correlated with qualitative characteristics of duram wheat meal and bran; recombinant expression vector in host cells; microorganism transformed with vector
10/26/1999US5973135 DNA comprising plum pox virus and tomato spotted wilt virus cDNAS for disease resistance
10/26/1999US5973134 Rat CNP complementary DNA and precursor protein
10/26/1999US5973133 Mutant S182 genes
10/26/1999US5973132 Expression of dna coding for house dust mite allergens.
10/26/1999US5973131 Diagnosis of systemic infections of penicillium marneffei by detecting the presence of the specific antibodies as well as the pmap1 protein antigen.
10/26/1999US5973130 Antiproliferative/antiarthric/antidiabetic/antiallergen andantiinflammatory agents; diagnosis and treatment of acquired immuno deficiency syndrome, crohn's/addison's diseases, ulcers, osteoporsis
10/26/1999US5973124 Native egg-white, recombinant, deglycosylated, bacterial or truncated avidin/strepavidin or derivatives with modified tyrosine at binding site, resulting in reduced pka; for reversible binding of biotin; reuse of chromatography matrix
10/26/1999US5973123 Monoclonal antibody, or fragment thereof, which has an affinity for native melanoma inhibitory activity protein
10/26/1999US5973122 Serum immunoregulatory polypeptides and uses therefor
10/26/1999US5973121 The ingestion of peanuts is a common cause of food hypersensitivity reactions.
10/26/1999US5973120 Bovine and human polynucleotides and peptides expressed by such polynucleotides which are useful in detecting goodpasture antibodies and treating goodpasture syndrome.
10/26/1999US5973119 Cyclin E genes and proteins
10/26/1999US5973118 A polypeptide which codes a trypsin inhibitor; for purification of tissue plasminogen activators
10/26/1999US5973117 Isolated and purified receptor protein endogenous to rt, bovine, or human, capable of binding a pituitary adneylate cyclase activating polypeptide (pacap) or salt, and amino acid sequences encoding it; diagnostic, e.g. of neuropathy
10/26/1999US5973116 Compounds for targeting
10/26/1999US5973115 Method for potentiating and inhibiting insulin-like growth factor activity
10/26/1999US5973114 Isolated purified growth hormone releasing hormone (ghrh) receptor of given molecular weight; made by solubilization of ghrh-r/ghrh complexes and extraction of bound ghrh using mild detergent followed by affinity chromatography
10/26/1999US5973112 Comprising tripeptide unit of the formula (xaaflpgly)n, where xaa is any amino acid, flp is 4(r)-fluoro-l-proline, and n is at least 7; increased stability; stronger triple helix than native collagen; for use such as in artificial skin
10/26/1999US5973110 Inhibiting the bio-activity of enzymes.
10/26/1999US5972902 DNA encoding human IL-6 receptor antagonist and protein encoded thereby
10/26/1999US5972901 Making a composition for delivering an oligonucleotide to a mammalian cell by providing a peptide target binding moiety being capable of binding to a serpin enzyme complex receptor, polylysine, an oligonucleotide vector; conjugating, coupling
10/26/1999US5972900 Conjugating target binding moiety consisting of an antibody or fragment which binds to secretory component of polymeric immunoglobulin receptor on surface of epithelium cell, nucleic acid binder, expression vector, compacting, administering
10/26/1999US5972899 Apoptosis induced by Shigella IpaB
10/26/1999US5972897 Acylated enol derivatives as prodrugs of elastase inhibitors
10/26/1999US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999US5972890 Polypeptide with label; diagnosis
1 ... 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 ... 2916